London Institute of Cancer Research: 'Pathfinder Molecules' Open New Route to Targeting an Underexploited Family of Potential Therapeutic Cancer Targets
August 07, 2026
August 07, 2026
LONDON, England, Aug. 7 (TNSjou) -- The Institute of Cancer Research issued the following news:
* * *
'Pathfinder molecules' open new route to targeting an underexploited family of potential therapeutic cancer targets
Researchers have taken a major step towards opening up an entirely new class of cancer drug targets by creating the first potent small-molecule inhibitors of the enzyme DHX8. This protein is involved in pre-mRNA splicing - a fundamen . . .
* * *
'Pathfinder molecules' open new route to targeting an underexploited family of potential therapeutic cancer targets
Researchers have taken a major step towards opening up an entirely new class of cancer drug targets by creating the first potent small-molecule inhibitors of the enzyme DHX8. This protein is involved in pre-mRNA splicing - a fundamen . . .